Literature DB >> 19596788

The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.

Shaodong Guo1, Kyle D Copps, Xiaocheng Dong, Sunmin Park, Zhiyong Cheng, Alessandro Pocai, Luciano Rossetti, Mini Sajan, Robert V Farese, Morris F White.   

Abstract

We used a Cre-loxP approach to generate mice with varied expression of hepatic Irs1 and Irs2 to establish the contribution of each protein to hepatic nutrient homeostasis. While nutrient-sensitive transcripts were expressed nearly normally in liver lacking Irs2 (LKO2 mice), these transcripts were significantly dysregulated in liver lacking Irs1 (LKO1 mice) or Irs1 and Irs2 together (DKO mice). Similarly, a set of key gluconeogenic and lipogenic genes was regulated nearly normally by feeding in liver retaining a single Irs1 allele without Irs2 (DKO/1 mice) but was poorly regulated in liver retaining one Irs2 allele without Irs1 (DKO/2 mice). DKO/2 mice, but not DKO/1 mice, also showed impaired glucose tolerance and insulin sensitivity-though both Irs1 and Irs2 were required to suppress hepatic glucose production during hyperinsulinemic-euglycemic clamp. In contrast, either hepatic Irs1 or Irs2 mediated suppression of HGP by intracerebroventricular insulin infusion. After 12 weeks on a high-fat diet, postprandial tyrosine phosphorylation of Irs1 increased in livers of control and LKO2 mice, whereas tyrosine phosphorylation of Irs2 decreased in control and LKO1 mice. Moreover, LKO1 mice -- but not LKO2 mice -- that were fed a high-fat diet developed postprandial hyperglycemia. We conclude that Irs1 is the principal mediator of hepatic insulin action that maintains glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596788      PMCID: PMC2738277          DOI: 10.1128/MCB.00138-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.

Authors:  Cullen M Taniguchi; Kohjiro Ueki; Ronald Kahn
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Metabolism: a higher power for insulin.

Authors:  Fiona M Gribble
Journal:  Nature       Date:  2005-04-21       Impact factor: 49.962

3.  Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.

Authors:  S Guo; G Rena; S Cichy; X He; P Cohen; T Unterman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Hypothalamic K(ATP) channels control hepatic glucose production.

Authors:  Alessandro Pocai; Tony K T Lam; Roger Gutierrez-Juarez; Silvana Obici; Gary J Schwartz; Joseph Bryan; Lydia Aguilar-Bryan; Luciano Rossetti
Journal:  Nature       Date:  2005-04-21       Impact factor: 49.962

Review 5.  Atypical protein kinase C in insulin action and insulin resistance.

Authors:  R V Farese; M P Sajan; M L Standaert
Journal:  Biochem Soc Trans       Date:  2005-04       Impact factor: 5.407

6.  Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.

Authors:  Seiji Ishii; Katsumi Iizuka; Bonnie C Miller; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

7.  Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.

Authors:  Alfonso Mora; Christopher Lipina; François Tronche; Calum Sutherland; Dario R Alessi
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

8.  Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.

Authors:  T Noguchi; T Matozaki; K Inagaki; M Tsuda; K Fukunaga; Y Kitamura; T Kitamura; K Shii; Y Yamanashi; M Kasuga
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

9.  Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes.

Authors:  K I Rother; Y Imai; M Caruso; F Beguinot; P Formisano; D Accili
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

10.  SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.

Authors:  K Kotani; P Wilden; T S Pillay
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

View more
  72 in total

1.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors.

Authors:  M P Sajan; R V Farese
Journal:  Diabetologia       Date:  2012-02-15       Impact factor: 10.122

Review 3.  Atypical protein kinase C in cardiometabolic abnormalities.

Authors:  Robert V Farese; Mini P Sajan
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

4.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

5.  BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.

Authors:  Mini P Sajan; Robert A Ivey; Robert V Farese
Journal:  Metabolism       Date:  2015-08-24       Impact factor: 8.694

Review 6.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

7.  Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression.

Authors:  Mini P Sajan; Robert A Ivey; Robert V Farese
Journal:  Diabetologia       Date:  2013-08-10       Impact factor: 10.122

Review 8.  Evidence for central regulation of glucose metabolism.

Authors:  Michelle Carey; Sylvia Kehlenbrink; Meredith Hawkins
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

Review 9.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

10.  Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.

Authors:  Hui Yan; Wangbao Yang; Fenghua Zhou; Xiaopeng Li; Quan Pan; Zheng Shen; Guichun Han; Annie Newell-Fugate; Yanan Tian; Ravikumar Majeti; Wenshe Liu; Yong Xu; Chaodong Wu; Kimberly Allred; Clinton Allred; Yuxiang Sun; Shaodong Guo
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.